Trang kết quả 12 cho Khu vực: Chăm sóc sức khỏe Ngành: Công nghệ sinh học Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (1012)
- Úc (58)
- Áo (16)
- Bỉ (7)
- Brazil (16)
- Canada (83)
- Trung Quốc (94)
- Đan Mạch (6)
- Phần Lan (4)
- Pháp (41)
- Đức (738)
- Hồng Kông (46)
- Ấn Độ (19)
- Ai-len (1)
- Israel (19)
- Ý (4)
- Nhật Bản (37)
- Mexico (28)
- Hà Lan (3)
- New Zealand (1)
- Na Uy (14)
- Ba Lan (9)
- Nga (2)
- Hàn Quốc (12)
- Tây Ban Nha (4)
- Thụy Điển (70)
- Thụy Sĩ (11)
- Đài Loan (67)
- Thái Lan (2)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (69)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (285)
- NasdaqGM (149)
- NasdaqGS (226)
- NSE (10)
- NYSE (10)
- NYSE American (19)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (112)
- OTC Markets OTCPK (125)
- OTC Markets OTCQB (38)
- OTC Markets OTCQX (8)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (47)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Chăm sóc sức khỏe (2611)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (2611)
Công nghệ sinh học (2611)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2611)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1705)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (553)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (419)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (501)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Ascendis Pharma A/S A71.F | $122 133.36 USD |
-4.69
|
$7.54B 8.24B USD | $50 54.66 USD | $122 133.36 USD | $122 133.36 USD | $7.54B 8.24B USD | 0 | -$6.53 -7.1 USD | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Akeso, Inc. 4RY.F | $8.05 8.8 USD |
+4.55
|
$7.49B 8.18B USD | $1K 1.09K USD | $7.8 8.53 USD | $8.3 9.07 USD | $7.49B 8.18B USD | 0 | -$0.07 -0.07 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.45 — |
0
|
$8.12B — | $2.5K — | $0.45 — | $0.45 — | $8.12B — | 45.39 | $0.01 — | |
| Sino Biopharmaceutical SBHMY | $8.76 — |
0
|
$7.83B — | $100 — | $10.3 — | $10.3 — | $7.83B — | 30.18 | $0.29 — | |
| Corcept Therapeutics Incorporated HTD.F | $66.58 72.78 USD |
+4.36
|
$7.13B 7.79B USD | $100 109.31 USD | $62 67.77 USD | $66.58 72.78 USD | $7.13B 7.79B USD | 58.92 | $1.13 1.24 USD | |
| Bio-Techne Corporation TE1.F | $42.8 46.79 USD |
-2.28
|
$6.91B 7.55B USD | $176 192.39 USD | $42.8 46.79 USD | $42.8 46.79 USD | $6.91B 7.55B USD | 47.55 | $0.9 0.98 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18 19.68 USD |
-6.74
|
$6.45B 7.05B USD | $50 54.66 USD | $17.05 18.64 USD | $18 19.68 USD | $6.45B 7.05B USD | 0 | -$4.49 -4.9 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $286.3 312.96 USD |
+3.32
|
$6.33B 6.92B USD | $99 108.22 USD | $264.1 288.7 USD | $286.4 313.07 USD | $6.33B 6.92B USD | 0 | -$20.06 -21.9 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $51.12 55.88 USD |
-6.65
|
$6.32B 6.9B USD | $2.13K 2.33K USD | $50.56 55.27 USD | $52.14 57 USD | $6.32B 6.9B USD | 16.28 | $3.14 3.43 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $99.38 108.64 USD |
+6.43
|
$6.09B 6.66B USD | $6 6.56 USD | $86.2 94.23 USD | $99.38 108.64 USD | $6.09B 6.66B USD | 12.53 | $7.93 8.67 USD | |
| Sarepta Therapeutics, Inc. S1RP34.SA | $16.56 3.36 USD |
+12.04
|
$32.14B 6.51B USD | $0 0 USD | $0 0 USD | $0 0 USD | $32.14B 6.51B USD | 24.00 | $0.69 0.14 USD | |
| Revolution Medicines, Inc. 42Z.F | $27.6 30.17 USD |
-3.5
|
$5.95B 6.5B USD | $50 54.66 USD | $27.6 30.17 USD | $27.6 30.17 USD | $5.95B 6.5B USD | 0 | -$3.26 -3.5 USD | |
| Roivant Sciences Ltd. 87S.F | $8 8.75 USD |
-6.93
|
$5.71B 6.24B USD | $600 655.88 USD | $7.98 8.73 USD | $8.16 8.92 USD | $5.71B 6.24B USD | 0 | -$0.92 -1.005 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $27.14 29.67 USD |
-5.63
|
$5.69B 6.22B USD | $380 415.39 USD | $27.14 29.67 USD | $27.14 29.67 USD | $5.69B 6.22B USD | 0 | -$2.62 -2.8 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$102.85B 6.09B USD | $0 0 USD | $0 0 USD | $0 0 USD | $102.85B 6.09B USD | 0 | -$62.95 -3.7 USD | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $100,100 75.56 USD |
+4.93
|
$7.84T 5.92B USD | $75.07K 56.66 USD | $98,700 74.5 USD | $101,100 76.31 USD | $7.84T 5.92B USD | 0 | $0 0 USD | |
| Legend Biotech Corporation 9LB.F | $29.2 31.92 USD |
+4.29
|
$5.36B 5.86B USD | $135 147.57 USD | $26.4 28.86 USD | $29.2 31.92 USD | $5.36B 5.86B USD | 0 | -$0.87 -0.9 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| Financière de Tubize SA FTD.F | $111.2 121.56 USD |
-1.94
|
$4.95B 5.41B USD | $70 76.52 USD | $111.2 121.56 USD | $111.2 121.56 USD | $4.95B 5.41B USD | 55.04 | $2.02 2.21 USD | |
| TG Therapeutics, Inc. NKB2.F | $31.34 34.25 USD |
-5.62
|
$4.92B 5.38B USD | $675 737.87 USD | $31.34 34.25 USD | $31.34 34.25 USD | $4.92B 5.38B USD | 223.82 | $0.14 0.15 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Financière de Tubize SA FTD.SG | $107.2 117.18 USD |
-6.29
|
$4.81B 5.26B USD | $0 0 USD | $107.2 117.18 USD | $109.8 120.03 USD | $4.81B 5.26B USD | 53.06 | $2.02 2.21 USD | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| Halozyme Therapeutics, Inc. HALO.MX | $680 40.26 USD |
0
|
$84B 4.97B USD | $0 0 USD | $680 40.26 USD | $680 40.26 USD | $84B 4.97B USD | 21.27 | $31.96 1.89 USD | |
| Telix Pharmaceuticals TLPPF | $14.68 — |
0
|
$4.91B — | $1.5K — | $12.7 — | $12.7 — | $4.91B — | 163.11 | $0.09 — | |
| Krystal Biotech, Inc. 4KB.SG | $139.95 152.98 USD |
-8.38
|
$4.43B 4.84B USD | $0 0 USD | $139.95 152.98 USD | $141.2 154.35 USD | $4.43B 4.84B USD | 51.26 | $2.73 2.98 USD | |
| Krystal Biotech, Inc. 4KB.F | $141.15 154.3 USD |
-7.68
|
$4.43B 4.84B USD | $17 18.58 USD | $141.15 154.3 USD | $141.15 154.3 USD | $4.43B 4.84B USD | 51.51 | $2.74 3 USD | |
| Blueprint Medicines Corporation 2L9.F | $67.54 73.83 USD |
-10.78
|
$4.32B 4.72B USD | $30 32.79 USD | $67.54 73.83 USD | $71.32 77.96 USD | $4.32B 4.72B USD | 0 | -$0.98 -1.07 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $43.75 47.82 USD |
-11.97
|
$4.25B 4.64B USD | $69 75.43 USD | $43.43 47.47 USD | $43.77 47.85 USD | $4.25B 4.64B USD | 20.44 | $2.14 2.34 USD | |
| Axsome Therapeutics, Inc. 19X.F | $85.82 93.81 USD |
-3.27
|
$4.22B 4.61B USD | $300 327.94 USD | $85.82 93.81 USD | $85.82 93.81 USD | $4.22B 4.61B USD | 0 | -$5.49 -6.001 USD | |
| ALK-Abelló A/S AKBLF | $21.35 — |
-4.47
|
$4.61B — | $100 — | $22.35 — | $22.35 — | $4.61B — | 39.53 | $0.54 — | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Alpine Immune Sciences ALPN | $64.97 — |
0
|
$4.46B — | $0 — | $0 — | $0 — | $4.46B — | 0 | $0 — | |
| Biocon Limited BIOCON.BO | $305.2 3.69 USD |
-5.33
|
$365.61B 4.42B USD | $163.28K 1.98K USD | $303.85 3.68 USD | $315.8 3.82 USD | $365.61B 4.42B USD | 45.48 | $6.71 0.08 USD | |
| Zealand Pharma A/S ZLDPF | $62.5 — |
+1.59
|
$4.42B — | $300 — | $60.48 — | $63 — | $4.42B — | 0 | -$2.38 — | |
| Cytokinetics, Incorporated KK3A.F | $30.4 33.23 USD |
-1.3
|
$4.02B 4.4B USD | $250 273.28 USD | $30.4 33.23 USD | $30.4 33.23 USD | $4.02B 4.4B USD | 0 | -$4.79 -5.2 USD | |
| ALK-Abelló A/S 4AJ0.F | $18 19.68 USD |
-1.26
|
$3.91B 4.28B USD | $16 17.49 USD | $17.73 19.38 USD | $18.35 20.06 USD | $3.91B 4.28B USD | 36.73 | $0.49 0.54 USD | |
| Agios Pharmaceuticals, Inc. AGIO.MX | $1,222 72.36 USD |
0
|
$70.02B 4.15B USD | $0 0 USD | $1,222 72.36 USD | $1,222 72.36 USD | $70.02B 4.15B USD | 5.16 | $236.58 14.01 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Mirati Therapeutics MRTX | $58.7 — |
0
|
$4.12B — | $0 — | $0 — | $0 — | $4.12B — | 0 | $0 — | |
| Ionis Pharmaceuticals, Inc. ISI.F | $22.73 24.85 USD |
-9.73
|
$3.61B 3.95B USD | $4 4.37 USD | $22.73 24.85 USD | $22.73 24.85 USD | $3.61B 3.95B USD | 0 | -$2.78 -3.03 USD | |
| Vaxcyte, Inc. 5VA.F | $27.8 30.39 USD |
-5.44
|
$3.61B 3.95B USD | $200 218.63 USD | $26 28.42 USD | $27.8 30.39 USD | $3.61B 3.95B USD | 0 | -$3.46 -3.7 USD | |
| Vaxcyte, Inc. 5VA.MU | $27.2 29.73 USD |
-9.33
|
$3.61B 3.95B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.61B 3.95B USD | 0 | -$3.46 -3.7 USD | |
| BB Biotech AG BB.MI | $65.2 71.27 USD |
0
|
$3.58B 3.91B USD | $10.08K 11.02K USD | $51.6 56.41 USD | $52.9 57.83 USD | $3.58B 3.91B USD | 5.75 | $11.32 12.37 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| CymaBay Therapeutics CBAY | $32.48 — |
0
|
$3.73B — | $0 — | $0 — | $0 — | $3.73B — | 0 | $0 — | |
| Zealand Pharma A/S 0NZU.IL | $408.8 59.94 USD |
-7
|
$24.37B 3.57B USD | $144 21.11 USD | $0 0 USD | $0 0 USD | $24.37B 3.57B USD | 0 | -$15.13 -2.2 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $48.8 53.34 USD |
-3.37
|
$3.23B 3.54B USD | $0 0 USD | $48.8 53.34 USD | $52 56.84 USD | $3.23B 3.54B USD | 0 | -$3.97 -4.3 USD | |
| 3SBio Inc. 83B.F | $1.28 1.4 USD |
-0.78
|
$3.14B 3.43B USD | $0 0 USD | $1.23 1.34 USD | $1.28 1.4 USD | $3.14B 3.43B USD | 11.63 | $0.11 0.12 USD | |
| Syngene International Limited SYNGENE.BO | $691.45 8.37 USD |
-0.51
|
$277.52B 3.36B USD | $4.83K 58.37 USD | $682.5 8.26 USD | $695 8.41 USD | $277.52B 3.36B USD | 55.22 | $12.52 0.15 USD | |
| Zai Lab Limited 1ZL.F | $25.4 27.77 USD |
-1.55
|
$2.93B 3.21B USD | $200 218.63 USD | $25.4 27.77 USD | $25.4 27.77 USD | $2.93B 3.21B USD | 0 | -$2.38 -2.6 USD | |
| Galapagos NV GXE.DE | $44.47 48.61 USD |
0
|
$2.93B 3.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.93B 3.2B USD | 0 | $0 0 USD | |
| VitaSpring Biomedical VSBC | $1 — |
0
|
$3.1B — | $100 — | $1 — | $1 — | $3.1B — | 0 | $0 — | |
| Camurus AB (publ) 7CA.F | $47.22 51.62 USD |
-5.18
|
$2.78B 3.04B USD | $32 34.98 USD | $47.22 51.62 USD | $47.22 51.62 USD | $2.78B 3.04B USD | 71.54 | $0.66 0.72 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $5.05 5.52 USD |
0
|
$2.74B 3B USD | $4 4.37 USD | $5.05 5.52 USD | $5.05 5.52 USD | $2.74B 3B USD | 15.30 | $0.33 0.36 USD | |
| Morphic Holding MORF | $56.99 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR | $18.96 — |
0
|
$2.86B — | $0 — | $0 — | $0 — | $2.86B — | 0 | $0 — | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $27.4 29.95 USD |
-7.43
|
$2.57B 2.81B USD | $191 208.79 USD | $27.4 29.95 USD | $27.4 29.95 USD | $2.57B 2.81B USD | 0 | -$5.76 -6.2 USD | |
| MorphoSys AG MOR.VI | $68.15 74.5 USD |
0
|
$2.57B 2.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.57B 2.81B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.DE | $67.25 73.51 USD |
0
|
$2.53B 2.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.53B 2.77B USD | 0 | $0 0 USD | |
| Genscript Biotech GNNSF | $1.28 — |
0
|
$2.76B — | $700 — | $1.9 — | $1.9 — | $2.76B — | 0 | -$0.08 — | |
| MorphoSys AG MPSYF | $73.27 — |
0
|
$2.76B — | $0 — | $0 — | $0 — | $2.76B — | 0 | $0 — | |
| Genscript Biotech Corporation G51.F | $1.12 1.22 USD |
-0.44
|
$2.51B 2.75B USD | $1K 1.09K USD | $1.12 1.22 USD | $1.12 1.22 USD | $2.51B 2.75B USD | 0 | -$0.07 -0.07 USD | |
| Merus N.V. 2GH.F | $29.4 32.14 USD |
-12.5
|
$2.49B 2.72B USD | $300 327.94 USD | $29.4 32.14 USD | $30.8 33.67 USD | $2.49B 2.72B USD | 0 | -$3.05 -3.3 USD | |
| Akero Therapeutics, Inc. 0K4.F | $30.22 33.03 USD |
-8.48
|
$2.48B 2.71B USD | $183 200.04 USD | $30.22 33.03 USD | $30.22 33.03 USD | $2.48B 2.71B USD | 0 | -$3.15 -3.4 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $46.6 50.94 USD |
-3
|
$2.38B 2.61B USD | $29 31.7 USD | $46.6 50.94 USD | $46.6 50.94 USD | $2.38B 2.61B USD | 17.99 | $2.59 2.83 USD | |
| MorphoSys AG 0NDV.IL | $67.6 73.9 USD |
0
|
$2.34B 2.56B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.34B 2.56B USD | 0 | $0 0 USD | |
| Scholar Rock Holding Corporation 2QK.F | $24.6 26.89 USD |
+3.36
|
$2.33B 2.55B USD | $60 65.59 USD | $21.2 23.17 USD | $24.6 26.89 USD | $2.33B 2.55B USD | 0 | -$2.25 -2.4 USD | |
| Veracyte, Inc. 12V.F | $26 28.42 USD |
-2.26
|
$2.31B 2.53B USD | $32 34.98 USD | $26 28.42 USD | $26 28.42 USD | $2.31B 2.53B USD | 92.85 | $0.28 0.31 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $18.55 20.28 USD |
-6.85
|
$2.25B 2.46B USD | $100 109.31 USD | $18.55 20.28 USD | $18.91 20.67 USD | $2.25B 2.46B USD | 15.45 | $1.2 1.31 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $12.55 13.71 USD |
-10.39
|
$2.15B 2.36B USD | $2.28K 2.5K USD | $12.55 13.71 USD | $12.55 13.71 USD | $2.15B 2.36B USD | 11.20 | $1.12 1.22 USD | |
| ImmunityBio, Inc. 26CA.F | $2.35 2.57 USD |
+7.49
|
$2.09B 2.28B USD | $6.55K 7.16K USD | $2.09 2.28 USD | $2.42 2.65 USD | $2.09B 2.28B USD | 0 | -$0.56 -0.6 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $22.4 24.49 USD |
-5.08
|
$2.08B 2.28B USD | $60 65.59 USD | $22.4 24.49 USD | $22.4 24.49 USD | $2.08B 2.28B USD | 0 | -$3.38 -3.6 USD | |
| Viking Therapeutics, Inc. 1VT.F | $18.52 20.24 USD |
-6.48
|
$2.08B 2.27B USD | $380 415.39 USD | $16.4 17.93 USD | $18.77 20.52 USD | $2.08B 2.27B USD | 0 | -$0.92 -1.005 USD | |
| SK bioscience Co.,Ltd. 302440.KS | $38,400 28.99 USD |
+7.11
|
$2.95T 2.23B USD | $93.01K 70.21 USD | $37,100 28 USD | $38,500 29.06 USD | $2.95T 2.23B USD | 0 | $0 0 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $15.96 17.44 USD |
-9.63
|
$2B 2.19B USD | $60 65.59 USD | $15.96 17.44 USD | $15.96 17.44 USD | $2B 2.19B USD | 0 | -$1.47 -1.6 USD | |
| Bavarian Nordic A/S BV3.DE | $25.3 27.66 USD |
0
|
$1.99B 2.18B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99B 2.18B USD | 0 | $0 0 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $25.2 27.55 USD |
-9.35
|
$1.93B 2.11B USD | $11 12.02 USD | $25.2 27.55 USD | $25.2 27.55 USD | $1.93B 2.11B USD | 0 | -$2.76 -3.01 USD | |
| ABL Bio Inc. 298380.KQ | $57,600 43.48 USD |
+9.51
|
$2.77T 2.09B USD | $3.9M 2.94K USD | $54,100 40.84 USD | $58,800 44.38 USD | $2.77T 2.09B USD | 0 | $0 0 USD | |
| Amicus Therapeutics, Inc. AM6.F | $6 6.56 USD |
-7.69
|
$1.84B 2.02B USD | $73 79.8 USD | $6 6.56 USD | $6 6.56 USD | $1.84B 2.02B USD | 0 | -$0.17 -0.1 USD | |
| Bavarian Nordic A/S 0DPB.IL | $143.73 21.07 USD |
-2.89
|
$13.49B 1.98B USD | $0 0 USD | $0 0 USD | $0 0 USD | $13.49B 1.98B USD | 10.20 | $14.09 2.07 USD | |
| Galapagos NV G1LP34.SA | $7.18 1.46 USD |
0
|
$9.46B 1.92B USD | $0 0 USD | $0 0 USD | $0 0 USD | $9.46B 1.92B USD | 0 | -$0.01 -0.002 USD | |
| Everest Medicines Limited 6HN.F | $5.15 5.63 USD |
0
|
$1.74B 1.9B USD | $50 54.66 USD | $5.15 5.63 USD | $5.15 5.63 USD | $1.74B 1.9B USD | 0 | -$0.4 -0.4 USD | |
| Denali Therapeutics Inc. 4DN.MU | $10.28 11.24 USD |
-4.46
|
$1.7B 1.86B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.7B 1.86B USD | 0 | -$2.34 -2.5 USD | |
| Denali Therapeutics Inc. 4DN.F | $10.17 11.12 USD |
-3.97
|
$1.7B 1.86B USD | $258 282.03 USD | $10.17 11.12 USD | $10.17 11.12 USD | $1.7B 1.86B USD | 0 | -$2.34 -2.5 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $34.6 37.82 USD |
-9.42
|
$1.7B 1.85B USD | $10 10.93 USD | $34.4 37.6 USD | $34.6 37.82 USD | $1.7B 1.85B USD | 0 | -$1.7 -1.8 USD | |
| Vericel Corporation ATQP.F | $33.6 36.73 USD |
-8.2
|
$1.68B 1.84B USD | $50 54.66 USD | $33.6 36.73 USD | $33.6 36.73 USD | $1.68B 1.84B USD | 186.66 | $0.18 0.2 USD | |
| Fusion Pharmaceuticals FUSN | $21.41 — |
0
|
$1.82B — | $0 — | $0 — | $0 — | $1.82B — | 0 | $0 — | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $86 94.01 USD |
-4.97
|
$1.66B 1.81B USD | $20 21.86 USD | $86 94.01 USD | $86.5 94.56 USD | $1.66B 1.81B USD | 0 | -$0.2 -0.2 USD | |
| Bavarian Nordic A/S BV3.F | $21.16 23.13 USD |
+11.37
|
$1.65B 1.8B USD | $590 644.95 USD | $18.85 20.6 USD | $21.16 23.13 USD | $1.65B 1.8B USD | 11.25 | $1.88 2.06 USD | |
| PeptiDream PPTDF | $13.75 — |
0
|
$1.78B — | $80 — | $11.21 — | $11.21 — | $1.78B — | 17.85 | $0.77 — | |
| Ambrx Biopharma AMAM | $28 — |
0
|
$1.77B — | $0 — | $0 — | $0 — | $1.77B — | 0 | $0 — | |
| Genus GENSF | $25.1 — |
0
|
$1.65B — | $300 — | $25.1 — | $25.1 — | $1.65B — | 0 | -$0.08 — | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||